Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2026 10:00 ET | Source: Persevere Therapeutics, Inc.

Persevere Therapeutics Launches as a Clinical-Stage Oncology Company with a Novel Phase 1b/2a Agent and Announces First Close of Seed Financing

Chesterbrook, PA, March 03, 2026 (GLOBE NEWSWIRE) -- Persevere Therapeutics, Inc. (“Persevere”), a Delaware-incorporated, clinical-stage oncology biotechnology company, today announced its official...
March 02, 2026 07:00 ET | Source: GT Biopharma, Inc.

GT Biopharma Reports Full Year 2025 Financial Results

Phase 1 trial evaluating GTB-3650 TriKE® continues to actively enroll, with the next update anticipated in Q3 2026 following completion of enrollment in dose Cohort 5 Phase 1 basket trial evaluating...
February 05, 2026 07:18 ET | Source: Research and Markets

Crohn's Disease (Regional Enteritis) Global Clinical Trials Market Review 2025: G7 and E7 Activities, Trial Status, Sponsor Insights, Enrollment Trends, Company Listings, Unaccomplished Trials

Dublin, Feb. 05, 2026 (GLOBE NEWSWIRE) -- The "Crohn's Disease (Regional Enteritis) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This...
December 01, 2025 11:11 ET | Source: Research and Markets

Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Market Review 2025

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This...
November 28, 2025 07:08 ET | Source: Research and Markets

$3.38 Bn Humanized Mice Model Market Trends, Opportunity, and Forecasts, 2020-2024 & 2025-2030

Dublin, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The "Humanized Mice Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
November 25, 2025 07:00 ET | Source: Pasithea

Pasithea Therapeutics Announces $1 Million Award by ALS Association to Study the Efficacy, Safety, and Tolerability of PAS-004 for Treatment of ALS

-- The ALS Association is the world's leading funder of amyotrophic lateral sclerosis (ALS) research -- -- The Hoffman ALS Clinical Trial Awards Program was created to fund early- to mid-stage...
November 14, 2025 05:26 ET | Source: Research and Markets

Inflammatory Bowel Disease Global Clinical Trials Market Review 2025: Insights on Trial Phases, Statuses, and Regional Trends

Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Inflammatory Bowel Disease - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report...
July 21, 2025 07:23 ET | Source: Research and Markets

CD5 Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025 | CD5 Therapies Reach Phase-II Trials with Less Than 10 in Pipeline

Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The "CD5 Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025" report has been added to ...
July 07, 2025 07:17 ET | Source: Research and Markets

mRNA Cancer Vaccines Clinical Trials & Future Market Outlook 2025: Personalized mRNA Cancer Vaccines Revolutionize Oncology with Neoantigen-Driven Immunotherapy

Dublin, July 07, 2025 (GLOBE NEWSWIRE) -- The "mRNA Cancer Vaccines Clinical Trials, Market Trends By Indication, Development Priority Status & Market Opportunity Insight 2025" drug pipelines...
April 29, 2025 07:02 ET | Source: Pasithea

Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Patients in Cohort 6 from its Phase 1 Trial of PAS-004 in Advanced Cancer Patients

Pasithea Therapeutics completes Cohort 6 enrollment and dosing in Phase 1 PAS-004 trial for MAPK-driven advanced cancers; full enrollment by 2025.